SCHEMBL31031185

SCHEMBL31031185

CNc1ncnc2c1ncn2[C@@H]1O[C@H](CO)[C@@H](OP(N)O)[C@H]1OC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 1/20 0.55
▸ KMT2A Q03164 1/20 0.55
▸ ADORA3 P0DMS8 3/20 0.50
▸ ADORA1 P30542 1/20 0.50
▸ LMNA P02545 2/20 0.47
▸ ALDH1A1 P00352 1/20 0.47
▸ GLA P06280 1/20 0.47
▸ PMP22 Q01453 1/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ NPC1 O15118 1/20 0.47
▸ NPY1R P25929 1/20 0.47
▸ HTT P42858 1/20 0.47
▸ NPY2R P49146 1/20 0.47
▸ RAB9A P51151 1/20 0.47
▸ SLC29A1 Q99808 1/20 0.47
▸ RXFP1 Q9HBX9 1/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ TSHR P16473 1/20 0.47
▸ NFKB1 P19838 1/20 0.47
▸ MAPK1 P28482 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9413275 0.90 MEN1 (0.62) MEN1KMT2AADORA3ADORA1
SCHEMBL23754814 0.87 ADORA3 (0.59) MEN1KMT2AADORA3ADORA1ALDH1A1
SCHEMBL20449961 0.84 MEN1 (0.74) MEN1KMT2AADORA3ADORA1
SCHEMBL18503544 0.84 MEN1 (0.74) MEN1KMT2AADORA3ADORA1
SCHEMBL26501998 0.84 MEN1 (0.63) MEN1KMT2AADORA3ADORA1
SCHEMBL25097801 0.84 MEN1 (0.74) MEN1KMT2AADORA3ADORA1
SCHEMBL29421079 0.84 MEN1 (0.74) MEN1KMT2AADORA3ADORA1
SCHEMBL25098313 0.84 MEN1 (0.74) MEN1KMT2AADORA3ADORA1
SCHEMBL7197194 0.84 MEN1 (0.74) MEN1KMT2AADORA3ADORA1
SCHEMBL665209 0.84 MEN1 (0.74) MEN1KMT2AADORA3ADORA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4658772-A1 IN VITRO TRANSCRIPTION METHODS AND COMPOUNDS FOR USE THEREIN Genscript USA Inc. (US) 2025-12-10 — — EP disclosed
WO-2024163689-A1 IN VITRO TRANSCRIPTION METHODS AND COMPOUNDS FOR USE THEREIN GENSCRIPT USA INC. (US) 2024-08-08 — — WO disclosed
Send feedback